JP4318856B2 - チモーゲン性核酸検出方法、および関連分子およびキット - Google Patents
チモーゲン性核酸検出方法、および関連分子およびキット Download PDFInfo
- Publication number
- JP4318856B2 JP4318856B2 JP2000534677A JP2000534677A JP4318856B2 JP 4318856 B2 JP4318856 B2 JP 4318856B2 JP 2000534677 A JP2000534677 A JP 2000534677A JP 2000534677 A JP2000534677 A JP 2000534677A JP 4318856 B2 JP4318856 B2 JP 4318856B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- primer
- dna
- zymogen
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 300
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 199
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 199
- 238000001514 detection method Methods 0.000 title description 9
- 230000003462 zymogenic effect Effects 0.000 title description 3
- 230000003197 catalytic effect Effects 0.000 claims abstract description 135
- 238000000034 method Methods 0.000 claims abstract description 133
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 88
- 230000000692 anti-sense effect Effects 0.000 claims abstract description 34
- 239000013615 primer Substances 0.000 claims description 156
- 108020004414 DNA Proteins 0.000 claims description 108
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 105
- 230000003321 amplification Effects 0.000 claims description 103
- 108010062466 Enzyme Precursors Proteins 0.000 claims description 102
- 102000010911 Enzyme Precursors Human genes 0.000 claims description 102
- 108091027757 Deoxyribozyme Proteins 0.000 claims description 72
- 230000000694 effects Effects 0.000 claims description 62
- 102000053602 DNA Human genes 0.000 claims description 40
- 239000000758 substrate Substances 0.000 claims description 34
- 238000003776 cleavage reaction Methods 0.000 claims description 29
- 230000007017 scission Effects 0.000 claims description 26
- 230000000295 complement effect Effects 0.000 claims description 22
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 14
- 108020001019 DNA Primers Proteins 0.000 claims description 12
- 239000003155 DNA primer Substances 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 9
- 230000002159 abnormal effect Effects 0.000 claims description 9
- 230000000977 initiatory effect Effects 0.000 claims description 9
- 238000012986 modification Methods 0.000 claims description 8
- 230000004048 modification Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 108700042226 ras Genes Proteins 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 5
- 241000204031 Mycoplasma Species 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000005096 rolling process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 4
- 238000003745 diagnosis Methods 0.000 claims description 4
- 238000001465 metallisation Methods 0.000 claims description 4
- 150000004032 porphyrins Chemical class 0.000 claims description 4
- 125000002652 ribonucleotide group Chemical group 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 241000288906 Primates Species 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 239000002689 soil Substances 0.000 claims description 3
- 208000030507 AIDS Diseases 0.000 claims description 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 2
- 208000018565 Hemochromatosis Diseases 0.000 claims description 2
- 208000005176 Hepatitis C Diseases 0.000 claims description 2
- 241000282412 Homo Species 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 241000700159 Rattus Species 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 201000008827 tuberculosis Diseases 0.000 claims description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000700198 Cavia Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 208000026350 Inborn Genetic disease Diseases 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 claims 1
- 238000006664 bond formation reaction Methods 0.000 claims 1
- 208000016361 genetic disease Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 48
- 101710113436 GTPase KRas Proteins 0.000 description 13
- 108090000994 Catalytic RNA Proteins 0.000 description 10
- 102000053642 Catalytic RNA Human genes 0.000 description 10
- 108091034117 Oligonucleotide Proteins 0.000 description 10
- 108091092562 ribozyme Proteins 0.000 description 10
- 108020004705 Codon Proteins 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 9
- 108010006785 Taq Polymerase Proteins 0.000 description 9
- 101150075118 sub1 gene Proteins 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- 108091093088 Amplicon Proteins 0.000 description 7
- 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000000329 molecular dynamics simulation Methods 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical group C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000282341 Mustela putorius furo Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
- 229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
- 102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- NLJUOWMZPAVXHU-UHFFFAOYSA-N prop-2-enamide;urea Chemical compound NC(N)=O.NC(=O)C=C NLJUOWMZPAVXHU-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical group C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6867—Replicase-based amplification, e.g. using Q-beta replicase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7689998P | 1998-03-05 | 1998-03-05 | |
| US60/076,899 | 1998-03-05 | ||
| PCT/IB1999/000754 WO1999045146A1 (en) | 1998-03-05 | 1999-02-22 | Zymogenic nucleic acid detection methods, and related molecules and kits |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002505117A JP2002505117A (ja) | 2002-02-19 |
| JP2002505117A5 JP2002505117A5 (https=) | 2006-04-20 |
| JP4318856B2 true JP4318856B2 (ja) | 2009-08-26 |
Family
ID=22134859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534677A Expired - Fee Related JP4318856B2 (ja) | 1998-03-05 | 1999-02-22 | チモーゲン性核酸検出方法、および関連分子およびキット |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US6140055A (https=) |
| EP (1) | EP1062367B1 (https=) |
| JP (1) | JP4318856B2 (https=) |
| KR (1) | KR100748863B1 (https=) |
| CN (1) | CN1167811C (https=) |
| AT (1) | ATE414169T1 (https=) |
| AU (1) | AU768627B2 (https=) |
| BR (1) | BR9908567A (https=) |
| CA (1) | CA2321948A1 (https=) |
| DE (1) | DE69939896D1 (https=) |
| IL (2) | IL164182A0 (https=) |
| WO (1) | WO1999045146A1 (https=) |
| ZA (1) | ZA991772B (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6261808B1 (en) * | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
| WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
| IL164182A0 (en) | 1998-03-05 | 2005-12-18 | Johnson & Johnson Res Pty Ltd | Zymogenic nucleic acid detection methods, and related molecules and kits |
| DE19811618C1 (de) * | 1998-03-17 | 2000-08-31 | Andreas Jenne | Ribozym codierende DNA und ein Oligonucleotidsubstrat enthaltende Zusammensetzung und Verfahren zur Messung von Transkriptionsraten |
| AUPQ495700A0 (en) * | 2000-01-05 | 2000-02-03 | Johnson & Johnson Research Pty. Limited | Method for concurrent amplification and real time detection of polymorphic nucleic acid sequences |
| US7205129B1 (en) * | 2000-02-28 | 2007-04-17 | Qiagen Gmbh | Method for reducing artifacts in nucleic acid amplification |
| AU2001268481A1 (en) * | 2000-06-15 | 2001-12-24 | Board Of Regents, The University Of Texas System | Regulatable, catalytically active nucleic acids |
| US7125660B2 (en) | 2000-09-13 | 2006-10-24 | Archemix Corp. | Nucleic acid sensor molecules and methods of using same |
| WO2003014375A2 (en) * | 2001-08-09 | 2003-02-20 | Archemix Corporation | Nucleic acid sensor molecules and methods of using same |
| US7297485B2 (en) * | 2001-10-15 | 2007-11-20 | Qiagen Gmbh | Method for nucleic acid amplification that results in low amplification bias |
| US6617137B2 (en) * | 2001-10-15 | 2003-09-09 | Molecular Staging Inc. | Method of amplifying whole genomes without subjecting the genome to denaturing conditions |
| US9487823B2 (en) | 2002-12-20 | 2016-11-08 | Qiagen Gmbh | Nucleic acid amplification |
| US7955795B2 (en) * | 2003-06-06 | 2011-06-07 | Qiagen Gmbh | Method of whole genome amplification with reduced artifact production |
| US8043834B2 (en) | 2003-03-31 | 2011-10-25 | Qiagen Gmbh | Universal reagents for rolling circle amplification and methods of use |
| BRPI0408967B8 (pt) | 2003-03-31 | 2021-07-27 | Hoffmann La Roche | kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas |
| EP1689764B1 (en) * | 2003-11-19 | 2013-01-02 | AlleLogic Biosciences Corporation | Oligonucleotides labeled with a plurality of fluorophores |
| US20050250134A1 (en) * | 2004-03-02 | 2005-11-10 | Dawei Sheng | Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof |
| US7939251B2 (en) | 2004-05-06 | 2011-05-10 | Roche Molecular Systems, Inc. | SENP1 as a marker for cancer |
| WO2006086499A2 (en) * | 2005-02-08 | 2006-08-17 | Applera Corporation | Nucleozymes and methods of use |
| US8309303B2 (en) | 2005-04-01 | 2012-11-13 | Qiagen Gmbh | Reverse transcription and amplification of RNA with simultaneous degradation of DNA |
| JP2008539730A (ja) * | 2005-05-02 | 2008-11-20 | ストラタジーン カリフォルニア | オリゴヌクレオチドのプローブ／プライマー組成物、及びポリヌクレオチドの検出方法 |
| EP1762627A1 (de) | 2005-09-09 | 2007-03-14 | Qiagen GmbH | Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion |
| EP2385141B1 (en) | 2005-10-07 | 2013-08-07 | SpeeDx Pty Ltd | Multicomponent nucleic acid enzymes and methods for their use |
| WO2007056312A2 (en) * | 2005-11-07 | 2007-05-18 | Clontech Laboratories, Inc. | Universal reporter tag for nucleozyme assays |
| CA2631881C (en) * | 2005-12-07 | 2015-03-24 | Tibotec Pharmaceuticals Ltd. | Methods, plasmid vectors and primers for assessing hiv viral fitness |
| WO2008001376A2 (en) * | 2006-06-28 | 2008-01-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Detection of analytes in a medium |
| DE102006035600B3 (de) * | 2006-07-27 | 2007-11-08 | Epigenomics Ag | Verfahren zum Nachweis eines Methylierungsmusters |
| EP1882746A3 (en) * | 2006-07-27 | 2008-03-19 | Epigenomics AG | Method for detecting a methylation pattern |
| JP5688507B2 (ja) * | 2006-10-06 | 2015-03-25 | スピーデクス ピーティーワイ リミテッド | 分子スイッチおよびそれらの使用のための方法 |
| US9938641B2 (en) * | 2006-12-18 | 2018-04-10 | Fluidigm Corporation | Selection of aptamers based on geometry |
| MX2009010710A (es) | 2007-04-05 | 2009-12-08 | Johnson & Johnson Res Pty Ltd | Complejos y enzimas de acido nucleico y metodos para su uso. |
| EP2071035A1 (en) | 2007-12-13 | 2009-06-17 | Epigenomics AG | Facilitator and method for amplification |
| WO2010147848A2 (en) | 2009-06-15 | 2010-12-23 | Rd Biosciences, Inc. | Kits and methods for selective amplification and detection of nucleic acid targets |
| CN101907573B (zh) * | 2010-08-17 | 2012-08-22 | 复旦大学 | 一种高灵敏度的集成cmos光学生物芯片 |
| US9051606B2 (en) | 2010-09-10 | 2015-06-09 | Qiagen Gaithersburg, Inc. | Methods and compositions for nucleic acid detection |
| JP6088487B2 (ja) | 2011-04-15 | 2017-03-01 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 走査リアルタイムマイクロ流体熱サイクラーと同期熱サイクリング及び走査光学検出の方法 |
| WO2013067202A1 (en) | 2011-11-04 | 2013-05-10 | Handylab, Inc. | Polynucleotide sample preparation device |
| AU2013202354A1 (en) * | 2012-06-18 | 2014-01-16 | Speedx Pty Ltd | Target detection and signal amplification |
| CN103013953B (zh) * | 2012-10-19 | 2014-09-17 | 中国科学院成都生物研究所 | 一种剪切dna的dna酶 |
| US20160202154A1 (en) * | 2013-09-05 | 2016-07-14 | Nec Solution Innovators, Ltd. | Method for producing sample and method for analyzing target |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4000159A (en) * | 1974-06-28 | 1976-12-28 | Phillips Petroleum Company | Preparation of n,n-disubstituted thioamides |
| US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5176995A (en) * | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| JP3276955B2 (ja) * | 1988-09-30 | 2002-04-22 | ジーン−トラック・システムス | Ｒｎａの鋳型の末端に結合したプローブ構造およびその使用方法 |
| US5112734A (en) * | 1989-05-26 | 1992-05-12 | Gene-Trak Systems | Target-dependent synthesis of an artificial gene for the synthesis of a replicatable rna |
| NZ241310A (en) * | 1991-01-17 | 1995-03-28 | Gen Hospital Corp | Trans-splicing ribozymes |
| GB9115909D0 (en) * | 1991-07-23 | 1991-09-04 | Nickerson Int Seed | Recombinant dna |
| EP1195442A3 (en) * | 1992-12-04 | 2002-07-31 | Innovir Laboratories, Inc. | Ribozyme amplified diagnostics |
| US5436143A (en) * | 1992-12-23 | 1995-07-25 | Hyman; Edward D. | Method for enzymatic synthesis of oligonucleotides |
| US5516664A (en) * | 1992-12-23 | 1996-05-14 | Hyman; Edward D. | Enzymatic synthesis of repeat regions of oligonucleotides |
| KR100218726B1 (ko) * | 1992-12-30 | 1999-09-01 | 김영환 | 고집적 반도체 소자의 접속장치 및 그 제조방법 |
| IL105894A (en) * | 1993-06-03 | 1997-02-18 | Asher Nathan | Method for the detection of nucleic acid sequence by using a detection ensemble and an amplification ensemble |
| US5582988A (en) * | 1994-09-15 | 1996-12-10 | Johnson & Johnson Clinical Diagnostics, Inc. | Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| US5807718A (en) * | 1994-12-02 | 1998-09-15 | The Scripps Research Institute | Enzymatic DNA molecules |
| IL111857A (en) * | 1994-12-02 | 1999-09-22 | Intelligene Ltd | Detection of nucleic acid sequences |
| MX9706501A (es) * | 1995-02-27 | 1998-02-28 | Intelligene Ltd | Deteccion de biomoleculas. |
| AUPN245295A0 (en) * | 1995-04-13 | 1995-05-11 | Johnson & Johnson Research Pty. Limited | Assay for genetic abnormalities |
| EP0833945B1 (en) * | 1995-06-07 | 2002-01-30 | Merck & Co., Inc. | Dna polymerase extension assay |
| JP4203126B2 (ja) * | 1997-04-29 | 2008-12-24 | ザ スクリップス リサーチ インスティテュート | 酵素ｄｎａ分子 |
| DE19805593A1 (de) * | 1998-02-12 | 1999-08-19 | Voith Sulzer Papiertech Patent | Eindicker |
| IL164182A0 (en) | 1998-03-05 | 2005-12-18 | Johnson & Johnson Res Pty Ltd | Zymogenic nucleic acid detection methods, and related molecules and kits |
-
1999
- 1999-02-22 IL IL16418299A patent/IL164182A0/xx unknown
- 1999-02-22 WO PCT/IB1999/000754 patent/WO1999045146A1/en not_active Ceased
- 1999-02-22 EP EP99914694A patent/EP1062367B1/en not_active Expired - Lifetime
- 1999-02-22 JP JP2000534677A patent/JP4318856B2/ja not_active Expired - Fee Related
- 1999-02-22 BR BR9908567-4A patent/BR9908567A/pt not_active Application Discontinuation
- 1999-02-22 AU AU33409/99A patent/AU768627B2/en not_active Ceased
- 1999-02-22 AT AT99914694T patent/ATE414169T1/de not_active IP Right Cessation
- 1999-02-22 KR KR1020007009783A patent/KR100748863B1/ko not_active Expired - Fee Related
- 1999-02-22 US US09/253,955 patent/US6140055A/en not_active Expired - Lifetime
- 1999-02-22 CN CNB998111147A patent/CN1167811C/zh not_active Expired - Fee Related
- 1999-02-22 IL IL13812699A patent/IL138126A0/xx not_active IP Right Cessation
- 1999-02-22 CA CA002321948A patent/CA2321948A1/en not_active Abandoned
- 1999-02-22 DE DE69939896T patent/DE69939896D1/de not_active Expired - Fee Related
- 1999-03-04 ZA ZA9901772A patent/ZA991772B/xx unknown
-
2000
- 2000-08-11 US US09/637,405 patent/US6201113B1/en not_active Expired - Lifetime
- 2000-12-21 US US09/746,985 patent/US6365724B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU768627B2 (en) | 2003-12-18 |
| ZA991772B (en) | 2000-10-12 |
| US6140055A (en) | 2000-10-31 |
| EP1062367A1 (en) | 2000-12-27 |
| JP2002505117A (ja) | 2002-02-19 |
| US6201113B1 (en) | 2001-03-13 |
| US6365724B2 (en) | 2002-04-02 |
| WO1999045146A1 (en) | 1999-09-10 |
| AU3340999A (en) | 1999-09-20 |
| ATE414169T1 (de) | 2008-11-15 |
| EP1062367A4 (en) | 2003-07-30 |
| KR100748863B1 (ko) | 2007-08-13 |
| IL138126A0 (en) | 2001-10-31 |
| IL164182A0 (en) | 2005-12-18 |
| CN1319142A (zh) | 2001-10-24 |
| CN1167811C (zh) | 2004-09-22 |
| KR20010041591A (ko) | 2001-05-25 |
| EP1062367B1 (en) | 2008-11-12 |
| US20010001063A1 (en) | 2001-05-10 |
| BR9908567A (pt) | 2000-12-12 |
| DE69939896D1 (de) | 2008-12-24 |
| CA2321948A1 (en) | 1999-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4318856B2 (ja) | チモーゲン性核酸検出方法、および関連分子およびキット | |
| JP2846018B2 (ja) | 核酸配列の増幅および検出 | |
| EP1985714B1 (en) | Method and kit for detecting a target molecule employing at least two affinity probes and rolling circle replication of padlock probes | |
| EP0361983A2 (en) | RNA template end-linked probe constructs and methods for use | |
| JP2002536981A (ja) | 核酸標的配列の存在を測定する方法およびその応用 | |
| JPH09512428A (ja) | リゾルベース開裂による突然変異の検出 | |
| EP1330546A2 (en) | Method for the amplification and optional characterisation of nucleic acids | |
| AU2002210862A1 (en) | Method for the amplification and optional characterisation of nucleic acids | |
| JP6638122B2 (ja) | 標的核酸の検出方法及びキット | |
| CA2143428A1 (en) | Method of nucleic acid-differentiation and assay kit for nucleic acid-differentiation | |
| WO2005072133A2 (en) | Nucleic acid detection | |
| CN116194591A (zh) | 序列转换反应 | |
| EP4310195A1 (en) | Method for nucleic acid detection using signal-mediated amplification of rna technology and rna aptamers | |
| US20120064528A1 (en) | Methods and reagents for quantifying nucleic acid fragmentation and apoptosis (qlm-pcr, cell number qpcr and apoqpcr) | |
| JP2982304B2 (ja) | 核酸の識別方法及び核酸の識別用検査セット | |
| CN120442798B (zh) | 单dNTP缺失结合聚合酶/连接酶反应检测基因突变的方法 | |
| JP2008245641A (ja) | 核酸の検出方法 | |
| AU2004201097A1 (en) | Zymogenic nucleic acid detection methods, and related molecules and kits | |
| WO1998002574A1 (fr) | Procede pour l'examen d'acides nucleiques et kits d'examen | |
| WO2006051991A1 (ja) | 核酸の増幅および検出方法 | |
| AU1523799A (en) | Methods and compositions for detection of specific nucleotide sequences | |
| JPH11198A (ja) | 標的塩基配列の検出方法 | |
| JPH11103894A (ja) | Ｄｎａの特異的検出方法 | |
| JPWO1996023077A1 (ja) | 遺伝子増幅用プライマー、該プライマーを用いた核酸の識別方法及び核酸の識別用検査セット | |
| JP2002058481A (ja) | メチル転移酵素の測定方法、そのためのプローブ及びキット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060222 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060222 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20071121 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081014 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090114 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090121 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090216 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090223 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090313 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090323 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090402 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090428 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090527 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120605 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130605 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |